These anti-tumor effects of CD8+ TRM cells were validated in the parabiosis model, which showed that CD8+ TRM cells do not recirculate in a preclinical murine tumor model, and this population enhanced the efficacy of cancer vaccine [51]. This evidence concerns the gene CD8A and cancer.